Recently, there has been debate about reducing newborn screening (NBS) thyroid‐stimulating hormone (TSH) cut‐offs to identify children with mild, but potentially clinically significant, thyroid deficiency. Once identified by NBS, these… Click to show full abstract
Recently, there has been debate about reducing newborn screening (NBS) thyroid‐stimulating hormone (TSH) cut‐offs to identify children with mild, but potentially clinically significant, thyroid deficiency. Once identified by NBS, these children will be referred to paediatric endocrinologists for further testing and possible treatment; however, variation in current clinical practice is not known. The aim of this study is to survey Paediatric Endocrinologists in Australia and New Zealand to gain insight into clinical practice for the treatment of mild thyroid deficiency.
               
Click one of the above tabs to view related content.